Back

Joint association of left bundle branch block and cardiomyopathy with incident heart failure: a prospective UK Biobank cohort study

29 August 2026 (14:15 - 14:45)
Organised by: Logo
Congress Presentation Part of: Heart failure at the crossroads: tafamidis, ageing, and vaccination Epidemiology, Prognosis, Outcome ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Sijing Cheng

Fuwai Hospital, CAMS and PUMC, Beijing (China)

4 More presentations in this session

Presentation thumbnail
The effectiveness of tafamidis to stabilize the disease progression of transthyretin amyloidosis in hereditary and wild-type subtypes
Miss M. Kharoubi (Creteil, FR)
Abstract Slides
Presentation thumbnail
Cardiohepatic collision: escalating mortality, stark disparities, and pandemic surge in chronic liver disease and heart failure – a 25-year US analysis
Doctor V. Purewal (Scottsdale, US)
Abstract Slides
Presentation thumbnail
Diverging trends in total and heart failure-specific disease burden by age: A 20-year nationwide study in Denmark
Miss C. Garred (Herlev, DK)
Abstract Slides
Presentation thumbnail
Frailty across the lifespan in heart failure: age-modified drivers and prognostic implications
Doctor V. Copeland (Ramat Gan, IL)
Abstract Slides

Access the full session

Session thumbnail
Heart failure at the crossroads: tafamidis, ageing, and vaccination

The Event

Event poster

ESC Congress 2026

29 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Left bundle branch block cardiomyopathy: an intriguing and defiant entity from diagnosis to treatment
22 May 2023
thumbnail
Congress Presentation
Outcomes and phenotypic expression of rare variants in hypertrophic cardiomyopathy genes in over 200,000 adults
28 August 2021
thumbnail
Congress Presentation
Effect of physical activity level on the association of LBBB, heart failure, and mortality
1 September 2024
thumbnail
Congress Presentation
Left ventricular non-compaction cardiomyopathy: predictors of heart failure progression requiring hospitalization
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources